Previous 10 | Next 10 |
Salt Lake City, UT, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the filing of its operating results on SEC Form 10-Q for the 3 mon...
Salt Lake City, Utah, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be presenting at the 71 st annual AACC Scientific ...
Sigma Labs (NASDAQ: SGLB ) +19% to work with airbus to deploy PrintRite3D rapid test and evaluation program More news on: Sigma Labs, Inc., Valeritas Holdings, Inc., RingCentral, Inc., Stocks on the move, Read more ...
Salt Lake City, UT, July 30, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the growing use of the Company’s Vector Smart™ NAM-W...
New York City, New York, July 23, 2019 (GLOBE NEWSWIRE) -- News from Co-Diagnostics, Inc. (Nasdaq: CODX) , a MedTech company with a patented platform for the development of molecular diagnostic tests, recently made CODX one of the hottest tickers of the day following the announcement of ...
Jaguar Health (NASDAQ: JAGX ) -31% . More news on: Jaguar Health, Inc., J. C. Penney Company, Inc., Marker Therapeutics, Inc., Stocks on the move, Read more ...
CODX stock is the biggest gainer on the Nasdaq after Co-Diagnostics Inc (NASDAQ:CODX) announced favorable results from a study to detect cancer mutations using its CoPrimer technology. Key Development Molecular diagnostics company Co-Diagnostics Inc, which has also created a patented pl...
Co-Diagnostics (NASDAQ: CODX ) is up 119% premarket, on announcing favorable results of a study to detect cancer mutations using its CoPrimer technology, with applications in liquid biopsy and companion diagnostic tests. More news on: Co-Diagnostics, Inc., Healthcare stocks n...
Salt Lake City, UT, July 18, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today favorable results of a study to detect cancer mutations using its ...
Gainers : Tower International (NYSE: TOWR ) +69% . Camber Energy (NYSEMKT: CEI ) +50% . HOOKIPA Pharma (NASDAQ: HOOK ) +28% . Milacron Holdings (NYSE: MCRN ) +25% . VivoPower International PLC (NASDAQ: VVPR ) +21% . ProQR Therapeutics N.V. (NASDAQ: PRQR ) +21% . Oasmi...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , April 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan PR Newswire SALT LAKE CITY , April 24, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, pate...
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event PR Newswire Ribbon-cutting included support from Mayor Wood of South Salt Lake and other dignitaries SALT LAKE CITY , April 12, 2024 /PRNewswire/ -- ...